Quality of life during acute and intermittent treatment of gastrooesophageal reflux disease with omeprazole compared with ranitidine. Results from a multicentre clinical trial

Italian Journal of Gastroenterology and Hepatology

Volumn 30, Issue 1, 1998, Pages 19-27

  Wiklund, I ^a   Bardhan, K D ^a   Miiller Lissner, S ^a   Bigard, M A ^a   Bianchi Porro, G ^a   Ponce, J ^a   Hosie, J ^a   Scott, M ^a   Weir, D ^a   Fulton, C ^a   Gillon, K ^a   Peacock, R ^a  

^a ASTRAZENECA R AND D   (Sweden)

Author keywords

Omeprazole; Quality of life; Ranitidine; Reflux disease

Indexed keywords

OMEPRAZOLE; RANITIDINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE; ENDOSCOPY; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE;

ADOLESCENT; ADULT; AGED; ANTI-ULCER AGENTS; DOUBLE-BLIND METHOD; EUROPE; FEMALE; FOLLOW-UP STUDIES; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; OMEPRAZOLE; QUALITY OF LIFE; QUESTIONNAIRES; RANITIDINE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 7144223431     PISSN: 11258055     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Adami HO, Agenas I, Gustavsson S, Loof L, Nyberg A, Nyren O, et al. The clinical diagnosis of "gastritis". Aspects of demographic epidemiology and health care consumption based on a nationwide sample survey. Scand J Gastroenterol 1984:19:216-9.
2. Jones RH, Lydeard SE, Hobbs FD, Kenkre JE, Williams El, Jones SJ, et al. Dyspepsia in England and Scotland. Gut 1990;31:401-5.
3. Spechler SJ. Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion 1992;51(Suppl l):24-9.
4. Glise H, Johansson B, Lindström C, Rosseland A, Hallerbäck B, Hultén S, et al. Gastro-oesophageal reflux dyspepsia-clinical findings. Effect of H2-receptor blockade and relapse during follow up. Submitted.
5. Joelsson B, Johnsson R Heartburn - the acid test. Gut 1989:30:1523-5.
6. Whitehead WE, Burnett CK, Cook E\V, Taub E. Impact of irritable bowel syndrome on quality of life. Dig Dis Sei 1996:41:2248-53.
7. Dent J. Long-term aims of treatment of reflux disease, and the role of non-drug measures. Digestion 1992;5I(Suppl l):30-4.
8. Bardhan KD, Miiller-Lissner S, Bigard MA, Bianchi Porro G, Ponce J, Hosie J, et al. Symptomatic gastroesophageal reflux disease (GORD): Intermittent treatment (IT) with omeprazole (OM) and ranitidine (RAN) as a strategy for management. Gastroenterology 1997;! 12(Suppl):A65.
9. Dimenäs E, Glise H, Hallerbäck B, Hernqvist H, Svedlund J, Wiklund I. Well-being and gastrointestinal symptoms among patients referred to endoscopy owing to suspected duodenal ulcer. Scand J Gastroenterol 1995:30:1046-52.
10. Dupuy HJ. The Psychological General Well-Being (PGWB) In-dex. In: Wenger NK, Mattson ME, Furberg CF, Elinson J, editors. Assessment of quality of life in clinical trials of cardiovascular therapies. New York: Le Jacq Publishing Inc. 1984:170-83.
11. Patrick D. Health-related quality of life in pharmaceutical evaluation. Forging progress and avoiding pitfalls. Pharmacoeconomics 1992;l:76~-8.
12. Wiklund I, Hailing K, Langström G. The Psychological General Well-Being (PGWB) index, a reliable tool for use in cross-cultural multicentre clinical trials. Qual Life Res 1995;4:A503.
13. Lind T, Havelund T, Carlsson R, Glise H, Hemqvist H, Junghard O, et al. The effect of omeprazole (OME) 20 mg and 10 mg daily on heartburn in patients with Endoscopy Negative Reflux Disease (ENRD). Gastroenterology 1995;108(Suppl):A151.
14. Dent J, Watts R, Riley S, Scheikh R, de Groot G, van Oudvorst A, et al. and the International GORD Study Group. Gastroesophageal Reflux Disease (GORD) in primary care - an international placebo controlled study of different treatment strategies with omeprazole. Gastroenterology 1996;! 10(Suppl):A93.
15. Venables T, Newland R, Patel AC, Hole J, Mulholland G, Turbitt M, et al. A comparison of omeprazole 10 mg and 20 mg with ranitidine 150 ma bd for the treatment of GORD in primary care. Gut 1995;37(Suppl 2):A45.
16. Dimenäs E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J . Gastroenterol 1996;31 (SuppI 221 ):8-13.
17. Rush DR, Stelmach WJ, Young TL, Kirchdoerfer LJ, ScottLennox J, Holverson HE, et al. Clinical effectiveness and quality of life with ranitidine vs placebo in gastroesophageal reflux disease patients: a clinical experience network (CEN) study. J Fam Pract 1995:41:126-36.
18. Mathias SD, Castell DO, Elkin EP, Matosian ML. Health-related quality of life of patients with acute erosive esophaaithis. Dig Dis Sei 1996:11:2123-9.
19. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH. Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. J Amer MedAss 1989:262:907-13.
20. :o Croog SH. Levine S, Testa MA, Brown B, Bulpitt CJ, Jenkins CD, et al. The effects of antihypertensive therapy on the quality of life. N Engl J Med 1986;314:1657-64.
21. Sjöland H, Wiklund I, Caidahl K, Haglid M, Westberg S, Herlitz J. Improvement in quality of life and exercise capacity after coronary bypass surgery. Arch Intern Med 1996; 156:265-71.
22. - Lind T, Havelund T, Carlsson R, Eriksson G, Glise H, Junghard O, et al. The effect of omeprazole (OME) 20 mg and 10 mg daily on heartburn in patients with endoscopy negative reflux disease (ERND) treated on an on-demand basis. Gastroenterology 1996:110:(Suppl)A178.
23. Lydeard S, Jones R. Factors affecting the decision to consult with dyspepsia: comparison of consulters and non-consulters. J R Coll Gen Pract 1989:39:495-8.